Editing Food and Drug Administration (section)

====Ebola treatment====
In 2014, the FDA added an [[Ebola]] treatment being developed by Canadian pharmaceutical company [[Tekmira Pharmaceuticals|Tekmira]] to the [[FDA Fast Track Development Program|Fast Track program]], but halted the phase 1 trials in July pending the receipt of more information about how the drug works. This was widely viewed as increasingly important in the face of a [[2014 West Africa Ebola outbreak|major outbreak of the disease in West Africa]] that began in late March 2014 and ended in June 2016.<ref>{{cite web | vauthors = Kliff S |title=The FDA recently halted trials on a potential Ebola treatment |url=https://www.vox.com/2014/8/3/5962381/ebola-outbreak-vaccine-fda-halted-trials |website=[[Vox (website)|Vox]] |access-date=August 4, 2014 |date=August 3, 2014 |archive-date=August 6, 2014 |archive-url=https://web.archive.org/web/20140806035748/http://www.vox.com/2014/8/3/5962381/ebola-outbreak-vaccine-fda-halted-trials |url-status=live}}</ref>